Skip to main content
Premium Trial:

Request an Annual Quote

Exosome Diagnostics, Promega Ink Sample Prep Kit Deal

NEW YORK (GenomeWeb News) – Exosome Diagnostics today said that Promega will be the exclusive supplier of its Urine Clinical Sample Concentrator Kit, which incorporates Exosome's technology for concentration of urinary exosomes.

The kit is sued for molecular diagnostic applications, and New York-based Exosome said that it will be used to process urine samples for clinical trials in genitourinary disorders, such as prostate cancer. Financial and other terms of the agreement weren't disclosed.

"This agreement is another important milestone in the execution of our molecular diagnostics commercial strategy," Exosome Diagnostics CEO James McCullough said in a statement. "We're pleased to be working with Promega, a manufacturer who has decades of experience in coupling the latest scientific advances in molecular biology with excellent cGMP manufacturing capability."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.